CUSIP: G0750W104
Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
25,387,747
-
Share change
-
+226,913
-
Total reported value
-
$291,478,000
-
Put/Call ratio
-
0%
-
Price per share
-
$11.48
-
Number of holders
-
69
-
Value change
-
-$2,125,452
-
Number of buys
-
37
-
Number of sells
-
30
Quarterly Holders Quick Answers
What is CUSIP G0750W104?
CUSIP G0750W104 identifies AXGT - AXOVANT SCIENCES LTD - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2016
-
Previous quarter:
Q4 2015
Recent filing periods for CUSIP G0750W104:
Institutional Holders of AXOVANT SCIENCES LTD - COM (AXGT) as of Q1 2016
As of 31 Mar 2016,
AXOVANT SCIENCES LTD - COM (AXGT) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,387,747 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, JANUS CAPITAL MANAGEMENT LLC, Visium Asset Management, LP, D. E. Shaw & Co., Inc., PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, FMR LLC, JPMORGAN CHASE & CO, PRIMECAP MANAGEMENT CO/CA/, and PERCEPTIVE ADVISORS LLC.
This page lists
69
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.